Brian Evans, singer and nominee for Hawaii’s 2nd congressional district, and the Physician-Patient Alliance for Health & Safety (PPAHS) announce plans to evaluate hospitals on their sleep apnea preparedness.
Helen Marie Bousquet tragically passed away after what is being described by her son, Mr. Evans, as “a basic routine procedure” for knee surgery. Mr. Evans said that her tragic and avoidable death highlights the need for better assessment of patients for sleep apnea and for better treatment and monitoring of such patients before, during and after surgery.
In an article for DoctorWeighsIn, Michael Wong, JD, discusses why opioids don’t just cause harm on the “street”. Opioids can kill people in hospital too!
Much of the public attention on the opioid-epidemic has been focused on the harm caused by prescription use and abuse of opioids. However, there is another facet that must be focused on: opioid-induced respiratory depression in clinical settings.
On September 5th and 6th, the Global Sepsis Alliance, initiator of World Sepsis Day and World Sepsis Congress, will host the 2nd World Sepsis Congress. The 2nd WSC is a free online congress in which over 100 renowned experts from all around the world will give presentations on all aspects of sepsis. The congress will be held in English and is open to everyone with an internet connection.
For more information on program, speakers, time zones, and to register for free, please visit www.worldsepsiscongress.org
On the 7th anniversary of the Physician-Patient Alliance for Health & Safety (PPAHS), PPAHS is pleased to release the Patient Monitoring Guide.
Since its first blog post 7 years ago, Michael Wong, JD (Founder and Executive Director, PPAHS) says PPAHS has advocated for continuous electronic monitoring of all patients receiving opioids. Mr. Wong explained that the primary motivation behind the Patient Monitoring Guide is to help answer questions posed by clinicians, hospital executives and risk managers about patient monitoring systems and to help them make decisions on which patient monitoring system best suits their clinical needs:
The Physician-Patient Alliance for Health & Safety remembers Amanda Abbiehl on her 8th death anniversary.
As reported by ABC News, “When Amanda Abbiehl’s parents kissed her goodnight on July 16, 2010, they never imagined it would be for the last time.”
Proper inhaler use can prevent many instances of respiratory compromise. In a recent survey, “The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers,” researchers from the American College of Chest Physicians surveyed 513 healthcare providers managing COPD and 499 patients with COPD across the United States and found that both patients and healthcare providers place less importance on inhaler devices than medication in the treatment of chronic obstructive pulmonary disease (COPD) and concluded:
COPD is a tremendous healthcare burden in the U.S. and worldwide, and it is important for patients and their clinicians to understand COPD’s role in respiratory compromise.
To better understand some of the key issues every patient and clinician should know about COPD’s role in respiratory compromise, the Physician-Patient Alliance for Health & Safety is pleased to release a clinical education podcast with the Society of Hospital Medicine’s COPD Team.
Researchers at the University of Colorado Hospital recently reported that their use of a PCA safety checklist was found to reduce pain from moderate-severe pain to no-mild pain in 42% of patients within 2 days. In “Let’s Be Smart About Improving Pain,” they reported:
Our PCA safety checklist smart phrases increased use of a safety checklist and documentation of daily PCA opioid trends, and correlated with more rapid improvement in moderate-severe pain levels.
Using benzodiazepines and opioids may be a deadly combination. According to the National Institute on Drug Abuse, more than 30% of opioid overdoses involve the use of benzodiazepines.
One of the commonly overlooked complications to safe opioid administration is failing to account for the additive sedation effects of non-opioid medication. In recognition of these dangers, in August 2016, the FDA issued its strongest warning about combined use of opioids and benzodiazepines and issued another caution more recently on September 20, 2017.
Recent survey points to the need for better education for COPD patients on how to use inhalers.
Chronic obstructive pulmonary disease (COPD) is a respiratory disorder that affects millions of patients and leads to substantial morbidity, mortality, disability, impaired quality of life, and increased health care costs. As the COPD Outcomes-based Network for Clinical Effectiveness & Research Translation (CONCERT) explains:
“Chronic Obstructive Pulmonary Disease (COPD) is a respiratory disorder that affects about 300 million patients worldwide and 30 million patients in the US alone. COPD carries a substantial burden in human suffering. Dyspnea and other respiratory symptoms are common and can be disabling. Respiratory infections and exposure to environmental triggers lead to episodic deteriorations (acute exacerbations of COPD; AE-COPD) and result in over 700,000 hospitalizations and 100,000 deaths each year in the U.S. alone.